Klaus Laimer Selected Research

Adjuvant Chemotherapy

7/2007

STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaus Laimer Research Topics

Disease

6	Neoplasms (Cancer) 08/2012 - 07/2007
5	Squamous Cell Carcinoma of Head and Neck 08/2012 - 12/2006
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2012 - 02/2007
1	Prostatic Neoplasms (Prostate Cancer) 08/2012
1	Colorectal Neoplasms (Colorectal Cancer) 02/2008
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2007

Drug/Important Bio-Agent (IBA)

3	ParaffinIBA 01/2008 - 02/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2012
1	AntigensIBA 08/2012
1	Proteins (Proteins, Gene)FDA Link 08/2012
1	Arachidonic Acid (Vitamin F)IBA 08/2012
1	PlatinumIBA 01/2012
1	Tumor Biomarkers (Tumor Markers)IBA 01/2012
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2011
1	Messenger RNA (mRNA)IBA 05/2011
1	PhosphoserineIBA 02/2009
1	Carrier Proteins (Binding Protein)IBA 02/2009
1	Surface Antigens (Surface Antigen)IBA 02/2008
1	Epithelial Cell Adhesion MoleculeIBA 01/2008
1	Tolonium Chloride FDA Link 12/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2012 - 07/2007
1	Therapeutics 02/2008
1	Oral Surgery (Maxillofacial Surgery) 01/2008
1	Adjuvant Chemotherapy 07/2007